Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | TDP2 | O95551 | 2/20 | 0.37 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.35 |
| ▸ | CCNB2 | O95067 | 2/20 | 0.34 |
| ▸ | CDK1 | P06493 | 2/20 | 0.34 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.34 |
| ▸ | GSK3B | P49841 | 2/20 | 0.34 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.34 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.34 |
| ▸ | CCNB3 | Q8WWL7 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 6/20 | 0.31 |
| ▸ | APP | P05067 | 4/20 | 0.31 |
| ▸ | RAF1 | P04049 | 3/20 | 0.31 |
| ▸ | MAP1LC3B | Q9GZQ8 | 2/20 | 0.31 |
| ▸ | RECQL | P46063 | 2/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.31 |
| ▸ | ARAF | P10398 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29851156 | 1.00 | TGM2 (0.43) | TGM2CES1TDP2LRRK2CCNB2 | |
| SCHEMBL11713736 | 0.82 | KDM4E (0.42) | GSK3BMAPTRECQLHSD17B10NTRK1 | |
| SCHEMBL21530513 | 0.79 | CA1 (0.42) | LRRK2MAPTCYP1A2CYP2C19KMT2A | |
| SCHEMBL7009777 | 0.79 | TGM2 (0.43) | TGM2CES1LRRK2CCNB2CDK1 | |
| SCHEMBL29851033 | 0.79 | CA1 (0.42) | LRRK2MAPTCYP1A2CYP2C19KMT2A | |
| SCHEMBL29851297 | 0.79 | TGM2 (0.43) | TGM2CES1LRRK2CCNB2CDK1 | |
| SCHEMBL21377067 | 0.77 | TDP2 (0.36) | TGM2CES1TDP2CA1CA2 | |
| SCHEMBL21530541 | 0.76 | PARP1 (0.41) | TDP2MEN1NFKB1KMT2ACA1 | |
| SCHEMBL21530478 | 0.76 | PDE3B (0.55) | LRRK2MAPTCYP1A2POLBCYP2C9 | |
| SCHEMBL29850920 | 0.76 | PDE3B (0.55) | LRRK2MAPTCYP1A2POLBCYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3478659-B1 | BENZOSULTAMS AND ANALOGUES AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2022-08-17 | — | — | EP | claimed |
| US-20190335753-A1 | BENZOSULTAMS AND ANALOGUES AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2019-11-07 | — | — | US | claimed |
| EP-3478659-B1 | BENZOSULTAMS AND ANALOGUES AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2022-08-17 | — | — | EP | disclosed |
| US-11219214-B2 | Benzosultams and analogues and their use as fungicides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2022-01-11 | — | — | US | disclosed |
| US-20200323211-A1 | BENZOSULTAMS AND ANALOGUES AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2020-10-15 | — | — | US | disclosed |
| US-10736321-B2 | Benzosultams and analogues and their use as fungicides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2020-08-11 | — | — | US | disclosed |
| US-20190335753-A1 | BENZOSULTAMS AND ANALOGUES AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2019-11-07 | — | — | US | disclosed |
| US-20040043985-A1 | 6,6-Fused heteroaryl derivatives as matrix metalloproteinase inhibitors | HICKS JAMES LESTER (US) | 2004-03-04 | — | — | US | disclosed |
| WO-2004014388-A1 | 6,6-FUSED HETEROARYL DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS | WARNER-LAMBERT COMPANY LLC (US) | 2004-02-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200323211-A1 | BENZOSULTAMS AND ANALOGUES AND THEIR USE AS FUNGICIDES | GABBR1, DPM1, CYP51A1 | TGM2 624/4885CES1 2140/4885TDP2 885/4885 |
| US-10736321-B2 | Benzosultams and analogues and their use as fungicides | GABBR1, DPM1, CYP51A1 | TGM2 624/4885CES1 2140/4885TDP2 885/4885 |
| US-20190335753-A1 | BENZOSULTAMS AND ANALOGUES AND THEIR USE AS FUNGICIDES | GABBR1, DPM1, CYP51A1 | TGM2 624/4885CES1 2140/4885TDP2 885/4885 |
| US-11219214-B2 | Benzosultams and analogues and their use as fungicides | GABBR1, DPM1, CYP51A1 | TGM2 624/4885CES1 2140/4885TDP2 885/4885 |
| US-20040043985-A1 | 6,6-Fused heteroaryl derivatives as matrix metalloproteinase inhibitors | MMP13, MMP26, MMP9 | TGM2 2877/4885CES1 2023/4885TDP2 1092/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.